SCHEMBL6824779

SCHEMBL6824779

O=C(NC1CCNCC1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 3/20 0.56
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 1/20 0.55
POLB P06746 1/20 0.55
MAPT P10636 1/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 1/20 0.55
TAS1R3 Q7RTX0 1/20 0.55
TAS1R2 Q8TE23 1/20 0.55
UTS2R Q9UKP6 8/20 0.54
HDAC8 Q9BY41 1/20 0.52
HTR2B P41595 2/20 0.50
ADRA2A P08913 1/20 0.50
HRH1 P35367 1/20 0.50
MCHR1 Q99705 1/20 0.50
HTR1A P08908 1/20 0.50
CYP2D6 P10635 1/20 0.50
DRD2 P14416 1/20 0.50
HTR1D P28221 1/20 0.50
HTR2C P28335 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1711760 0.87 TAS1R3 (0.57) SMYD3MEN1KMT2ATAS1R3TAS1R2
SCHEMBL12200364 0.87 HTR4 (0.57) SMYD3KDM4EMEN1POLBMAPT
SCHEMBL28684619 0.84 NPC1 (0.66) KDM4EMEN1POLBMAPTMAPK1
SCHEMBL6824522 0.83 MEN1 (0.56) SMYD3MEN1KMT2AHDAC8
SCHEMBL6823619 0.83 CNR2 (0.57) SMYD3KDM4EPOLBMAPTKMT2A
Hydrochloric Acid SCHEMBL7527565 0.81 MEN1 (0.55) SMYD3MEN1KMT2AHDAC8
SCHEMBL6824208 0.81 L3MBTL1 (0.76) MEN1KMT2A
SCHEMBL3222814 0.81 MAPK14 (0.58) SMYD3MEN1KMT2A
SCHEMBL5438942 0.80 F10 (0.54) SMYD3
SCHEMBL6820557 0.79 TAS1R3 (0.52) KDM4EMEN1POLBMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004076444-A2 NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC F. HOFFMANN-LA ROCHE AG (CH) 2004-09-10 WO disclosed
CN-1132828-C O-substd. hydroxy coumaranone derivs as antineoplastic and antitransfer agent ROCH DIAGNOSIS EQUIPMENT AG (DE) 2003-12-31 CN disclosed
US-6307051-B1 UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTAGONISTS AND HAVE ANTITUMOR AND ANTIMETASTATIC ACTIVITY. ROCHE DIAGNOSTICS GMBH (DE) 2001-10-23 US disclosed
CN-1266850-A O-substd. hydroxy coumaranone derivs as antineoplastic and antitransfer agent ROCH DIAGNOSIS EQUIPMENT AG (DE) 2000-09-20 CN disclosed
EP-1026165-A1 O-substituted Hydroxycoumaranone derivatives as antitumor and antimetastatic agents Roche Diagnostics GmbH (DE) 2000-08-09 EP disclosed